LongLFCRSep 2026
Lifecore Biomedical, Inc.
Greenhaven's thesis centers on monetizing Lifecore's excess pharmaceutical manufacturing capacity. The company added seven customers in nine months, including at least two that…
LFCR
Which hedge funds are long LFCR?
1 published idea on Lifecore Biomedical, Inc. across 1 fund — 1 long and 0 short.
Each entry below comes from a hedge fund's own investor letter, not a 13F filing, so it carries the reasoning behind the position on Lifecore Biomedical, Inc.: the full thesis, the risks the manager flagged, the conviction level and the time horizon. Positions may have changed since the letter was written.